Literature DB >> 19665123

Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice.

Mehran Haidari1, Philip R Wyde, Silvio Litovsky, Deborah Vela, Muzammil Ali, S Ward Casscells, Mohammad Madjid.   

Abstract

OBJECTIVE: Influenza can trigger heart attacks, and vaccination against influenza reduces the risk of cardiovascular events. Currently, it is believed that influenza virus in general does not disseminate to extra-pulmonary tissues. We assessed the vascular effects of influenza infection and whether the virus can directly infect atherosclerotic arteries in mice. METHODS/
RESULTS: We intranasally infected 4 different types of mice--atherosclerotic apo E-deficient (our primary model), LDL receptor knockout, C57BL/6, and outbred Swiss--with influenza A/HK (H3/N2) virus. On day 7 after infection, we cultured viable virus from lung, aorta, and heart tissue, but not from the blood of apo E-deficient mice. Immunofluorescence studies showed influenza A virus NP1 protein and real time polymerase chain reaction (PCR) assay showed RNA in the aorta of infected apo E-deficient mice. Infected mice had significantly higher blood levels of chemokines and cytokines than control mice. At the local level, gene expression for several chemokines and cytokines was increased and eNOS expression was decreased. Infected mice had a higher density of macrophages in plaque than did control mice.
CONCLUSIONS: We have shown for the first time that influenza virus can directly infect and reside in atherosclerotic arteries and that infection was associated with systemic and arterial-level pro-inflammatory changes. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19665123     DOI: 10.1016/j.atherosclerosis.2009.07.028

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

1.  Seasonal Influenza Infections and Cardiovascular Disease Mortality.

Authors:  Jennifer L Nguyen; Wan Yang; Kazuhiko Ito; Thomas D Matte; Jeffrey Shaman; Patrick L Kinney
Journal:  JAMA Cardiol       Date:  2016-06-01       Impact factor: 14.676

Review 2.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

3.  Inhibition of MLC phosphorylation restricts replication of influenza virus--a mechanism of action for anti-influenza agents.

Authors:  Mehran Haidari; Wei Zhang; Leila Ganjehei; Muzammil Ali; Zhenping Chen
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

4.  Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction.

Authors:  Xiuru Guan; Wei Yang; Xijuan Sun; Lanfeng Wang; Benjiang Ma; Hongyuan Li; Jin Zhou
Journal:  Inflamm Res       Date:  2012-02-29       Impact factor: 4.575

5.  Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.

Authors:  Charlie C Hsu; Jisun Paik; Thea L Brabb; Kevin D O'Brien; Jinkyu Kim; Brittany G Sullivan; Kelly L Hudkins; Audrey Seamons; Jennifer C Finley; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

6.  Murine norovirus increases atherosclerotic lesion size and macrophages in Ldlr(-/-) mice.

Authors:  Jisun Paik; Yvette Fierce; Phuong-Oanh Mai; Susan R Phelps; Thomas McDonald; Piper Treuting; Rolf Drivdahl; Thea Brabb; Renee LeBoeuf; Kevin D O'Brien; Lillian Maggio-Price
Journal:  Comp Med       Date:  2011-08       Impact factor: 0.982

Review 7.  Heart-lung interaction via infection.

Authors:  Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2014-01

8.  Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.

Authors:  Yun Wu; He Huang
Journal:  Exp Ther Med       Date:  2017-09-01       Impact factor: 2.447

Review 9.  The Weight of Obesity in Immunity from Influenza to COVID-19.

Authors:  Fernanda B Andrade; Ana Gualberto; Camila Rezende; Nathércia Percegoni; Jacy Gameiro; Eugenio D Hottz
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

Review 10.  In Vivo Models to Study the Pathogenesis of Extra-Respiratory Complications of Influenza A Virus Infection.

Authors:  Edwin Veldhuis Kroeze; Lisa Bauer; Valentina Caliendo; Debby van Riel
Journal:  Viruses       Date:  2021-05-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.